Remedica Ltd

Remedica recalls specific batches of medications

2026-08-10

On August 10, 2026, Cyprus-based pharmaceutical company Remedica Limited announced a voluntary recall of specific batches of two of its medicinal products—Carvedilol 25 mg Tablets and Clonazepam 0.5 mg Tablets—affecting multiple batch numbers with expiry dates ranging from 2026 to 2028, though the company emphasized that the recall does not apply to every package of these medications, urging consumers to carefully check the batch number printed on their packaging against the provided list. Remedica, a globally operating firm founded in 1980 with a presence in over 140 countries and a portfolio of more than 300 generics, branded generics, and OTC products, operates three cutting-edge facilities approved by health authorities across Europe and beyond, reinforcing its commitment to quality and safety. Patients who have the affected products are advised not to discontinue their prescribed medication without consulting a doctor or pharmacist, and to verify their batch numbers to determine if their specific packages are subject to the recall.